Company Therapeutics Programs Diagnostic Programs Research & Discovery Collaborations Investors
 
Compugen Reports Sale of a Portion of its Evogene Holdings|Jun 30, 2009
Compugen Announces Additional Grants from Israel Office of Chief Scientist for Validation Studies of Therapeutic Candidates |Jun 24, 2009